Baxter BioPharma Solutions’ FOYA award-winning facility in Halle/Westfalen, Germany, offers state-of-the-art parenteral cGMP manufacturing at one location, enabling processing solutions to fit your compound.
Serving client needs from clinical development through commercial launch with over 60 years of oncology manufacturing experience, the facility is uniquely designed to deliver high-quality products with optimum efficiency and speed to market.
Specialized areas of focus:
- Antibody-Drug Conjugates (ADCs)
- Highly Potent Compounds
- Lyophilized Products